Jane Street Group, LLC Genprex, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 16, 2021	SELL	$2.59 - $3.36 $26,159 - $33,936	-10,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.11 - $4.87 $100,453 - $157,301	-32,300 Reduced 76.18%	10,100 $34,000
Q1 2021 May 18, 2021	BUY	$3.66 - $7.67 $110,898 - $232,401	30,300 Added 250.41%	42,400 $183,000
Q4 2020 Feb 17, 2021	BUY	$3.03 - $5.51 $36,663 - $66,671	12,100 New	12,100 $50,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.